Form 4: Mesa Laboratories SVP Operations' Stock Options Expire Unexercised

Sentiment:

Insider Transaction Report


Mesa Laboratories' SVP of Operations, Brian David Archbold, reported the expiration of 2,129 unexercised non-qualified stock options on June 10, 2025.

Worse than expectedThe expiration of 2,129 non-qualified stock options unexercised implies that the market price of Mesa Laboratories' common stock was below the options' exercise price of $203.54 at the time of expiration, rendering them out-of-the-money for the holder.

Summary

  • Brian David Archbold, the Senior Vice President of Operations at Mesa Laboratories Inc. (MLAB), filed a Form 4 reporting changes in his beneficial ownership of company securities.
  • The filing indicates that 2,129 non-qualified stock options (NSOs) held by Mr. Archbold expired unexercised on June 10, 2025.
  • These options had an exercise price of $203.54 per share.
  • The NSOs were granted on June 10, 2019, and vested 1/4 on each anniversary date of the grant.
  • Following this transaction, Mr. Archbold directly beneficially owns 12,567 derivative securities.

Sentiment

Score: 5

Explanation: This is a routine insider transaction filing (Form 4) reporting the expiration of unexercised stock options. While the expiration itself might imply the stock price was below the strike, the filing itself is a standard disclosure and doesn't inherently convey strong positive or negative sentiment about the company's current operations or future prospects.

Negatives

  • 2,129 non-qualified stock options with an exercise price of $203.54 expired unexercised, suggesting the market price of MLAB common stock was below the exercise price at the time of expiration, or the holder chose not to exercise for other reasons.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider's securities transactions and does not provide broader industry context or trends.

Stakeholder Impact

  • Shareholders: The expiration of these options means no new shares will be issued from this specific grant, preventing potential dilution from this source. However, if the options expired out-of-the-money, it could reflect a stock price that has not performed well relative to the strike price, which is a broader concern for shareholders.
  • Employees (specifically the reporting person): The reporting person lost the potential value from these options, as they were not exercised before their expiration.

Key Dates

DateDescription
06/10/2019Grant date of Non-Qualified Stock Options (NSOs).
06/10/2020First vesting date for NSOs (1/4 vested).
06/10/25Expiration date of Non-Qualified Stock Options (NSOs).
06/11/2025Date of Form 4 filing.

Keywords

SEC Form 4, Insider Transaction, Stock Options, Mesa Laboratories, MLAB, Beneficial Ownership, Derivative Securities, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.